AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Mylan Laboratories increases 2006-2007 adjusted guidance to $1.35-$1.55/diluted share and reports record diluted EPS of $0.35 for 1Q 2006-2007. [5 tables in original article].
(From Chemical Business NewsBase - Company Reports - CBNB)
Mylan Laboratories Inc announced its financial results for 1Q ended Jun 2006, which included record GAAP earnings/diluted share of $0.35 and record net revenues of $348.8 M for 1Q 2006-2007 ($321.01 M in 1Q 2005-2006). Net earnings for 1Q 2006-2007 were $75.6 M (net earnings of $42.9 M in 1Q 2005-2006). Research and development expenses decreased to $21.2 M for 1Q 2006-2007 ($25.2 M in 1Q 2005-2006). The company also provided updated guidance of $1.35-$1.55/ diluted share for year ending Mar 2007. Mylan Laboratories Inc …
-
- Mylan Laboratories reports 2Q 2006-2007 adjusted diluted EPS of $0.37. [4...
-
News wire article from: Chemical Business Newsbase
November 1, 2006
700+ words
-
- Event Brief of Q4 2004 Mylan Laboratories Earnings Conference Call - Final.
-
News wire article from: Fair Disclosure Wire
May 11, 2004
700+ words
-
- Event Brief of Q3 2008 Mylan Laboratories Earnings Conference Call - Final.
-
News wire article from: Fair Disclosure Wire
February 27, 2008
700+ words
-
- Event Brief of Q1 2007 Mylan Laboratories Earnings Conference Call - Final.
-
News wire article from: Fair Disclosure Wire
July 26, 2006
700+ words
-
- Event Brief of Q3 2006 Mylan Laboratories Earnings Conference Call - Final.
-
News wire article from: Fair Disclosure Wire
February 2, 2006
700+ words
